Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

How are these TSX cannabis stocks faring?

Published 2023-03-12, 11:04 p/m
© Reuters.  How are these TSX cannabis stocks faring?
AURR
-

Kalkine Media -

Highlights:

  • Canadian cannabis stocks are grouped into recreational growers, ancillary businesses, and biotechnology companies.
  • Canopy Growth (TSX:WEED), a Canadian company with its headquarters in Smiths Falls
  • Aurora Cannabis (TSX:ACB) is a Canadian company that cultivates and sells medicinal and recreational cannabis.
The Canadian cannabis industry has contributed $43 billion to Canada's gross domestic product (GDP) ever since the legalization and created around 150,000 jobs, according to a 2022 Deloitte report.

Canadian cannabis stocks are grouped into recreational growers, ancillary businesses, and biotechnology companies.

Some of the top Canadian cannabis stocks include Canopy Growth, Aurora Cannabis, and OrganiGram Holdings (TSX:OGI).

Canopy Growth Corporation (TSX: WEED) Canopy Growth, a Canadian company headquartered in Smiths Falls, cultivates and markets hemp and medical and recreational cannabis under various brands, including Tweed and CraftGrow.

The company primarily operates in Canada and has distribution and production licenses in over a dozen nations. Additionally, Canopy can purchase Acreage Holdings once the federal cannabis industry in the United States is legalized.

As for the stock's future, the company recently announced that it had secured an agreement with an institutional investor to purchase and sell up to US$150 million of senior unsecured convertible debentures.

In Q3 2023, the company's net revenue was C$ 101.2 million, down by 28 per cent year-over-year (YoY).

Aurora Cannabis (TSX: ACB) Aurora Cannabis is a Canadian company that cultivates and sells medicinal and recreational cannabis. It has a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. The company is headquartered in Edmonton, Alberta, and primarily operates in Canada, but it has expanded internationally with medical cannabis exporting agreements or cultivation facilities in over 20 countries.

Valour, a novel cannabis cultivar created for veterans by veterans, was announced recently by Aurora. 5 per cent of the net profit via the sale of Valour will be donated to veteran organizations across Canada.

In Q2 2023, the cannabis revenues were up 20 per cent from Q1 2023. Meanwhile, the net revenue was C$ 61.7 million.

The net cash at the end of the second quarter of fiscal 2023 was C$ 130.28 million compared to C$ 48.94 million in Q2 2022.

Please note, the above content constitutes a very preliminary observation based on the industry and is of limited scope without any in-depth fundamental valuation or technical analysis. Any interest in stocks or sectors should be thoroughly evaluated taking into consideration the associated risks.

Read more on Kalkine Media

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.